Review of the CURB-65 Score for Pneumonia Severity

The CURB-65 Score for Pneumonia Severity is a clinical decision support tool designed to predict the 30-day mortality risk of community-acquired pneumonia (CAP) utilizing patient age, mental status, vital signs, and renal function. It assists healthcare providers during the initial evaluation and triage of patients presenting with acute respiratory infections. By calculating a stratified risk score, the tool supports safe disposition practices and helps prevent adverse outcomes by identifying whether patients are suitable for outpatient care, require hospital admission, or need intensive care management. In addition, this tool outlines the predicted mortality rate for each risk bracket and provides evidence-based recommendations to guide providers in safely allocating medical resources. Since its inception, the tool has been validated for use with CAP, but has seen emerging evidence in predicting mortality in influenza and COVID-19 pneumonia.

Authors

Institutions

Publication Details

Journal
Evidence to Action Official Journal of MDCalc
Published
2026-10-16
DOI
https://doi.org/10.65357/001c.171841
Primary Topic
Pneumonia and Respiratory Infections
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Review of the CURB-65 Score for Pneumonia Severity

Arman Hussain
Evidence to Action Official Journal of MDCalc
Pneumonia and Respiratory Infections
article

Review of the CURB-65 Score for Pneumonia Severity

Arman Hussain
article en

Abstract

The CURB-65 Score for Pneumonia Severity is a clinical decision support tool designed to predict the 30-day mortality risk of community-acquired pneumonia (CAP) utilizing patient age, mental status, vital signs, and renal function. It assists healthcare providers during the initial evaluation and triage of patients presenting with acute respiratory infections. By calculating a stratified risk score, the tool supports safe disposition practices and helps prevent adverse outcomes by identifying whether patients are suitable for outpatient care, require hospital admission, or need intensive care management. In addition, this tool outlines the predicted mortality rate for each risk bracket and provides evidence-based recommendations to guide providers in safely allocating medical resources. Since its inception, the tool has been validated for use with CAP, but has seen emerging evidence in predicting mortality in influenza and COVID-19 pneumonia.

Evidence to Action Official Journal of MDCalcVol. 032026(01)
George Washington University (US)
Good health and well-being
Openalex Percentile: Top 13%
Pneumonia and Respiratory Infections
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.